Viewing StudyNCT00134953



Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00134953
Status: TERMINATED
Last Update Posted: 2007-12-17
First Post: 2005-08-23

Brief Title: Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Cognitive Symptoms
Keywords:
Name View
Mild Cognitive Impairment MCI View
Mild cognitive impairment View
Alzheimers disease View
Dementia View